Monitor for the effectiveness of the registration statement and the first trade date. The key catalyst will be the announcement of a definitive business combination target. Given the China focus, watch for any PRC regulatory filings or CFIUS notifications that could signal deal progress or obstacles. The downsized offering may indicate softer demand; track the final pricing and any redemptions at the business combination vote.
Executive Summary
Southern Cross Acquisition II Corp. (SCAT) filed Amendment No. 2 to its S-1 registration statement for a $75 million SPAC IPO, down from the $100 million proposed in the prior S-1 filed 41 days ago. The offering is for 7.5 million units at $10.00 per unit, each consisting of one ordinary share, one redeemable warrant (exercise price $11.50), and one right to receive one-fourth of an ordinary share. The company has significant ties to China and may pursue a business combination there, exposing investors to heightened regulatory and enforcement risks related to PRC laws, CFIUS review, and PCAOB access. The downsized offering and complex risk profile make this a neutral filing with moderate impact, as the structure is standard for a SPAC but the China nexus introduces material uncertainty.
Key Financial Metrics
Key Facts
- Offering size reduced from $100M (10M units) in the July 8 S-1 to $75M (7.5M units) in this S-1/A.
- Each unit priced at $10.00 consists of one ordinary share, one redeemable warrant ($11.50 strike), and one right to receive 1/4 ordinary share upon business combination.
- Sponsor (Southern Cross Acquisition II Sponsor Corp.) paid $25,000 for 2.875M founder shares (~$0.0087/share), resulting in immediate and substantial dilution for public shareholders.
- Company has 12 months from closing to complete a business combination or will liquidate the trust account.
- All officers, directors, and the sponsor's sole shareholder are located outside the U.S. (New Zealand, China, Hong Kong, Singapore), creating enforcement risks for U.S. investors.
- Company may pursue targets in China, subjecting it to PRC regulatory approvals (CSRC, CAC), CFIUS review, and potential PCAOB access issues under the HFCAA.
- Proceeds of $75,187,500 (or $86,465,625 with over-allotment) will be held in a U.S. trust account, invested in U.S. government securities or money market funds.
- Sponsor and D. Boral Capital will purchase 224,550 private units at $10.00 each in a concurrent private placement.
- Founder shares are locked up until the earlier of 3 months post-business combination or a liquidation event, with early release if share price exceeds $12.00 for 20 of 30 trading days starting 90 days post-combination.
- Company's auditor, TAAD LLP, is U.S.-based and PCAOB-inspected, mitigating delisting risk under the HFCAA for the SPAC itself, but not for a potential China-based target.
Financial Impact
Offering size reduced from $100M to $75M. Sponsor paid $25,000 for shares worth $20M at IPO price, creating ~99% dilution for public shareholders at the per-share level (excluding rights value).
Risk Factors
- PRC regulatory uncertainty: potential need for CSRC/CAC approvals for a China-based target could delay or block a business combination.
- CFIUS risk: as a foreign person, the company may be prohibited from acquiring U.S. targets in sensitive industries.
- Enforcement risk: all officers/directors are outside the U.S., making it difficult for shareholders to enforce judgments.
- Dilution risk: founder shares purchased at ~$0.0087 vs. $10.00 IPO price create massive dilution for public holders.
- Liquidation risk: if no business combination is completed within 12 months, warrants and rights expire worthless and shareholders receive only the trust proceeds (~$10.025/share).
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001929980-26-000479 |
| Document: scacii_ex11.htm | 0001929980-26-000479 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 21d ago | 8-K | — | awaiting T+20 | — | — |
Aug 26, 2026 8w ago | EFFECT | — | awaiting T+20 | — | — |
Aug 18, 2026 9w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers